Who We Are

Oyster Venture Partners consists of a multi-disciplinary team of highly experienced operational deal makers who have worked across the biotechnology, therapeutic, diagnostic, medical technology, digital healthcare and healthcare
sectors around the globe. Our culture centres on closely partnering our client base, throughout the capital raising process supporting all levels of experienced leaders with a wide range of funding and corporate transactions.

The Team

David D’Alton
Executive Chairman

Rupert Lewis
CEO

Kaarel Aulik
Analyst

M:+44 7836 22 44 22
E: david.dalton@oystervp.com

LinkedIn

40 years’ international business development experience in corporate information technology (IBM and Digital Equipment Corp), and in Life Sciences in SME-level innovation.  Oyster co-founder and lead sponsor of Oyster’s unique platform solution to accelerate investment capital raising processes.
M: +44 7860 640 444
E: rupert.lewis@oystervp.com

LinkedIn

25+ years’ international corporate transaction experience, with a driving passion for supporting innovation in healthcare.  Oyster co-founder and lead sponsor of Oyster’s unique platform solution to accelerate investment capital raising processes.

LinkedIn

10+ years experience within the healthcare sector, supporting strategic decision making through market analytics and insight generation. Leading Oyster’s database stratification to fast track the matching of founder to funder.

Dr Gilles Devillers
Venture Advisor

Dr Kris Motmans, PhD
Venture Partner

Carl Weir
Venture Partner

LinkedIn

Serial Entrepreneur in the
pharmaceutical and biotech
industry. A scientific, engineering
and business background in
negotiation, strategic marketing,
drug delivery, pharma and
biotechnology.

LinkedIn

Serial advisor within the life science sector, covering both public and private transactions, covering investment sourcing and completion.

LinkedIn

Serial advisor and innovator with a track record of business & digital transformation, product strategy and advisory across finance, legal, AI, ML, Big Data, blockchain, payments, and digital healthcare.

Dr Laurent Pacheco, MD, MBA, PhD (Econ.)
Venture Partner

LinkedIn

Seasoned healthcare finance and consulting professional, previously PwC healthcare and former Managing Director of market access and health economics at Syneos Health. Trained a medical Doctor, MBA and PhD in Economics, alumni of the Private Equity Institute at the University of Oxford.

Rupert Lewis
CEO

M: +44 (0)7860 640444
E: rupert.lewis@oystervp.com

LinkedIn

20+ years corporate transaction experience across the globe, with a driving passion for supporting innovation in healthcare. Lead sponsor of Oyster’s unique platform solution to accelerate the capital raising process.

David D’Alton
Chairman

M: +44 (0)7836 224422
E: david.dalton@oystervp.com
LinkedIn
30+ years international business development and capital raising experience across the life science spectrum. Lead Partner with the UK Government’s Department of International Trade (DIT) Life Sciences Organisation (LSO)

Kaarel Aulik
Analyst

M: +44 (0)749 684 7155
E: kaarel.aulik@oystervp.com

LinkedIn

10+ years experience within the healthcare sector, supporting strategic decision making through market analytics and insight generation. Leading Oyster’s database stratification to fast track the matching of founder to funder.

Dr Gilles Devillers
Venture Advisor

LinkedIn

Serial Entrepreneur in the
pharmaceutical and biotech
industry. A scientific, engineering
and business background in
negotiation, strategic marketing,
drug delivery, pharma and
biotechnology.

Carl Weir
Venture Partner

LinkedIn

Serial advisor and innovator with a track record of business & digital transformation, product strategy and advisory across finance, legal, AI, ML, Big Data, blockchain, payments, and digital healthcare.

Dr Laurent Pacheco, MD, MBA, PhD (Econ.)
Venture Partner

LinkedIn

Seasoned healthcare finance and consulting professional, previously PwC healthcare and former Managing Director of market access and health economics at Syneos Health. Trained a medical Doctor, MBA and PhD in Economics, alumni of the Private Equity Institute at the University of Oxford.

Dr Kris Motmans, PhD
Venture Partner and Chief Scientific Investment Officer

LinkedIn

Serial advisor within the life science sector, covering both public and private transactions, covering investment sourcing and completion.